Financhill
Sell
21

CUTR Quote, Financials, Valuation and Earnings

Last price:
$0.32
Seasonality move :
6.59%
Day range:
$0.30 - $0.33
52-week range:
$0.28 - $4.97
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.04x
P/B ratio:
--
Volume:
591.5K
Avg. volume:
336.9K
1-year change:
-90.6%
Market cap:
$6.6M
Revenue:
$212.4M
EPS (TTM):
-$6.58

Analysts' Opinion

  • Consensus Rating
    Cutera has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of --, Cutera has an estimated upside of 509.76% from its current price of $0.33.
  • Price Target Downside
    According to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $0.33.

Fair Value

  • According to the consensus of 0 analysts, Cutera has 509.76% upside to fair value with a price target of -- per share.

CUTR vs. S&P 500

  • Over the past 5 trading days, Cutera has underperformed the S&P 500 by -6.91% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Cutera does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Cutera revenues have been falling on a year-over-year basis for 7 quarters in a row. In the most recent quarter Cutera reported revenues of $32.5M.

Earnings Growth

  • Cutera has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Cutera reported earnings per share of -$1.94.
Enterprise value:
369.4M
EV / Invested capital:
2.20x
Price / LTM sales:
0.04x
EV / EBIT:
--
EV / Revenue:
2.38x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-3.07x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$9.2M
Return On Assets:
-45.6%
Net Income Margin (TTM):
-92.59%
Return On Equity:
--
Return On Invested Capital:
-62.63%
Operating Margin:
-111.44%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $250.7M $230.2M $155.2M $46.5M $32.5M
Gross Profit $139.3M $92.9M $9.2M $6.5M $1.8M
Operating Income -$34.7M -$104.2M -$144.7M -$40.9M -$36.2M
EBITDA -$70.6M -$94.8M -$121.8M -$39.2M -$33.8M
Diluted EPS -$4.21 -$5.72 -$6.58 -$2.22 -$1.94
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $96.3M $242.1M $366.3M $311.3M $160.5M
Total Assets $123.4M $268.4M $428.2M $406.6M $234.4M
Current Liabilities $45.1M $63.1M $98.3M $92.4M $55.7M
Total Liabilities $71.4M $213.1M $412.7M $522.7M $487.3M
Total Equity $52M $55.3M $15.5M -$116.1M -$252.9M
Total Debt $7.2M $134M $300.3M $418.1M $420.4M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations -$47.3M -$120.9M -$116.6M -$36.9M -$24.7M
Cash From Investing -$220M $165M -$3.7M $35.5M -$173K
Cash From Financing $151.4M $89.5M -$924K $229K -$419K
Free Cash Flow -$62M -$160.1M -$120.4M -$42.4M -$24.9M
CUTR
Sector
Market Cap
$6.6M
$45.9M
Price % of 52-Week High
6.6%
46.95%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
-90.6%
-32.15%
Beta (5-Year)
1.263
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $0.34
200-day SMA
Sell
Level $1.23
Bollinger Bands (100)
Sell
Level 0.41 - 0.81
Chaikin Money Flow
Sell
Level -47.8M
20-day SMA
Sell
Level $0.37
Relative Strength Index (RSI14)
Sell
Level 38.16
ADX Line
Sell
Level 13.82
Williams %R
Neutral
Level -79.2056
50-day SMA
Sell
Level $0.45
MACD (12, 26)
Sell
Level -0.03
25-day Aroon Oscillator
Buy
Level 20
On Balance Volume
Neutral
Level 10.4M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-1.3277)
Sell
CA Score (Annual)
Level (-5.1132)
Sell
Beneish M-Score (Annual)
Level (-1.4788)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (7.559)
Sell
Piotroski F Score (Annual)
Level (3)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (4)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Cutera Inc is a medical device company that specializes in designing, developing, manufacturing, marketing, and servicing laser and other energy-based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States segment. Its products enable medical practitioners to perform safe procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions.

Stock Forecast FAQ

In the current month, CUTR has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CUTR average analyst price target in the past 3 months is --.

  • Where Will Cutera Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Cutera share price will rise to -- per share over the next 12 months.

  • What Do Analysts Say About Cutera?

    Analysts are divided on their view about Cutera share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cutera is a Sell and believe this share price will drop from its current level to --.

  • What Is Cutera's Price Target?

    The price target for Cutera over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is CUTR A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Cutera is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of CUTR?

    You can purchase shares of Cutera via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cutera shares.

  • What Is The Cutera Share Price Today?

    Cutera was last trading at $0.32 per share. This represents the most recent stock quote for Cutera. Yesterday, Cutera closed at $0.33 per share.

  • How To Buy Cutera Stock Online?

    In order to purchase Cutera stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Coinbase Stock Going Down?
Why Is Coinbase Stock Going Down?

Every way you look at it, Coinbase has had a…

Is Uber Stock a Buy on the Dip?
Is Uber Stock a Buy on the Dip?

Shares of Uber Technologies (NYSE:UBER) have been fading fast in…

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 115x

Buy
54
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
50
LMND alert for Dec 28

Lemonade [LMND] is down 10.69% over the past day.

Sell
50
TSLL alert for Dec 28

Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.

Buy
63
SMLR alert for Dec 28

Semler Scientific [SMLR] is down 9.65% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock